drugset / Press release
ALK-Abelló, Grazax® approved in Europe
2006-09-25 · ALK-Abelló A/S · original alk.net ↗
Authorities in 27 European countries have now approved GRAZAX®, ALK-Abelló's tablet-based vaccine against grass pollen allergy. ALK-Abelló still expects to launch GRAZAX® on the first European markets by the end of 2006 and ahead of the 2007 pollen season.
The release as fetched from its publisher. alk.net ↗